FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Conjunctiva topics
Conjunctiva
Conjunctival
Ophthalmic
Presbyopia
Accommodation
Aqueous Humor
Anterior Chamber
Anterior Chamber Of The Eye
Prostaglandin
Intraocular
Treatments
Shape Memory Polymer
Cross Section
Neuropathy
Form Factor

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Conjunctiva patents



      
           
This page is updated frequently with new Conjunctiva-related patents. Subscribe to the Conjunctiva RSS feed to automatically get the update: related Conjunctiva RSS feeds.

Subscribe to updates on this page: Conjunctiva RSS RSS

Date/App# patent app List of recent Conjunctiva-related patents
03/20/14
20140080765
 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein patent thumbnailNovel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
Selenium-lactoferrin according to the present invention has an excellent therapeutic effect on corneal and conjunctival diseases, and is suitable for mass production on an industrial scale.. .
02/06/14
20140037712
 Methods for preventing or treating eye diseases using adiponectin patent thumbnailMethods for preventing or treating eye diseases using adiponectin
A composition for preventing or treating an eye disease includes adiponectin as an active ingredient. Adiponectin as an active ingredient is eventually revealed to show prevention or therapeutic efficacies for eye diseases such as dry eye (syndrome), inflammatory eye disease and side effects due to the use of contact lenses by promoting tear secretion, alleviating ocular surface irregularities, decreasing inflammatory cytokines on the ocular surface and lacrimal gland, and increasing conjunctival goblet cell density.
01/30/14
20140028979
 Methods and apparatus to identify eye coverings for vision patent thumbnailMethods and apparatus to identify eye coverings for vision
Methods and apparatus can fit coverings to treat eyes. The covering can be identified so as to provide improved flow of tear liquid under the covering.
12/19/13
20130337557
 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases patent thumbnailUse of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-jun amino terminal kinase, jnk inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory eye diseases, such as inflammatory diseases of the blephara, conjunctiva, cornea, sclera, the vitreous body, uvea, ciliary body, choroid, orbital bone, lacrimal gland, or iris, in particular wherein the inflammatory disease is selected from hordeolum, chalazion, conjunktivitis, keratitis, scleritis, episcleritis, endophthalmitis, panophtalmitis, irititis, uveitis, cyclitis, chorioiditis, orbital phlegmon, and myositis of the eye muscle etc.. .
12/12/13
20130330383
 Ocular drug delivery system patent thumbnailOcular drug delivery system
An ocular drug delivery system can include a composition in which a formulation including recombinant human growth hormone (rhgh) is contained in a polymer matrix. The composition is configured for placement in or on the eye of a subject, and provides controlled release of an amount of the rhgh to the eye effective to promote healing of a conjunctival, sclera and or corneal wound..
10/24/13
20130281454
 Prostaglandin and vasoconstrictor pharmaceutical  compositions and methods of use patent thumbnailProstaglandin and vasoconstrictor pharmaceutical compositions and methods of use
Compositions containing a prostaglandin agent and a vasoconstrictor agent for ophthalmic applications are provided as well as methods of treating ophthalmic diseases using the same. In certain embodiments, the compositions and methods are useful for treating glaucoma without causing conjunctival hyperemia..
10/17/13
20130274724
 Methods and devices for treating presbyopia patent thumbnailMethods and devices for treating presbyopia
Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia.
10/17/13
20130274692
 Subconjuctival implant for posterior segment drug delivery patent thumbnailSubconjuctival implant for posterior segment drug delivery
A therapeutic device can be configured to place the reservoir substantially between the conjunctiva and the scleral such that the size of the reservoir can be increased and the size of the scleral penetration decreased so as to decrease invasiveness. The device may comprise a substantially constant reservoir volume and drug release mechanism, in which the volume of the reservoir and mechanism are tuned to receive a quantity of therapeutic agent with a volume of injected formulation and release the therapeutic agent for an extended time with a release rate profile.
10/10/13
20130267887
 Aqueous humor micro-bypass shunts patent thumbnailAqueous humor micro-bypass shunts
A small shunt can be placed within the eye to aid in drainage of aqueous humor from the anterior chamber of the eye to a pocket between the conjunctiva and the sclera to be absorbed, or to secrete through the cornea or the sclera external to the eye for glaucoma or ocular hypertension treatment. This drainage can decrease the pressure of the eye and potentially modify the course of advancing glaucomatous optic neuropathy as it relates to eye pressure.
09/19/13
20130245119
 Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders patent thumbnailTherapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders
The present invention provides an effective and safe prophylactic and therapeutic pharmaceutical agent and supplement for corneal epithelium disorders and/or conjunctival epithelial disorders. This is a therapeutic and/or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelial disorders comprising eicosapentaenoic acid and/or docosahexaenoic acid, a glycerin ester or phospholipid comprising these fatty acids as constituent fatty acids, or a lower alcohol ester of these fatty acids as active ingredients.
08/29/13
20130226008
Calculating conjunctival redness
The present application includes methods, systems and computer readable storage devices for determining a color score for at least a portion of a biological tissue. The subject matter of the application is embodied in a method that includes obtaining a digital image of the biological tissue, and receiving a selection of a portion of the image as an evaluation area.
08/15/13
20130211335
Apparatus for injection into an eye
The invention relates to an apparatus for injection into an eye comprising of a means for displacing a conjunctival layer of the eye over an underlying scleral layer of the eye so as to form a fold in the conjunctival layer, and means for guiding a needle through the conjunctival layer once the fold has been formed.. .
08/08/13
20130202678
Puf-a and related compounds for treatment of retinopathies and sight-threatening ophthalmologic disorders
Methods and compositions for treating retinal diseases comprising therapeutic amounts of a compound selected from a normal puf-a gene product, an active polypeptide fragment thereof, an analog thereof or a peptidomimetic thereof. Vectors, including aav vectors comprising the therapeutic compound are provided.
07/25/13
20130189217
Methods of using ophthalmic compositions comprising povidone-iodine
A topical ophthalmic composition comprised of povidone-iodine 0.01% to 10.0% combined with a steroid or non-steroidal anti-inflammatory drug. This solution is useful in the treatment of active infections of at least one tissue of the eye (e.g., conjunctiva and cornea) from bacterial, mycobacterial, viral, fungal, or amoebic causes, as well as treatment to prevent such infections in appropriate clinical settings (e.g.
06/06/13
20130144279
Methods for treating hyperopia and presbyopia via laser tunneling
A method for treating presbyopia utilizes an erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia.
06/06/13
20130144128
Ocular insert apparatus and methods
A comfortable insert comprises a retention structure sized for placement under the eyelids and along at least a portion of conjunctival sac of the upper and lower lids of the eye. The retention structure resists deflection when placed in the conjunctival sac of the eye and to guide the insert along the sac when the eye moves.
05/23/13
20130131577
Uveoscleral drainage device
An ophthalmic shunt implantable in an eye having an elongate body and a branched conduit for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye and the subconjunctival space, and a plate extending from an upper surface of the elongate body.. .
05/16/13
20130123195
Sustained action formulation of cyclosporin form 2
Disclosed herein are methods of treating diseases of the eye by administering to the subconjunctival space a formulation comprising cyclosporin a form 2 and a hydrogel.. .
05/16/13
20130122064
Ophthalmic depot formulations for periocular or suconjunctival administration
The present invention relates to ophthalmic depot formulations comprising an active agent, e.g. Embedded in a pharmacologically acceptable biocompatible polymer or a lipid encapsulating agent, e.g.
04/11/13
20130090612
Ocular insert apparatus and methods
A comfortable insert comprises a retention structure sized for placement under the eyelids and along at least a portion of conjunctival sac of the upper and lower lids of the eye. The retention structure resists deflection when placed in the conjunctival sac of the eye and to guide the insert along the sac when the eye moves.
04/04/13
20130085484
Methods for treating eye conditions
Systems and methods are provided for reducing intraocular pressure in an eye. A perpendicular incision is made through a conjunctiva of the eye to access a trabecular meshwork of the eye.
03/28/13
20130077044
Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
An eye covering such as a contact lens may comprise one or more structures to pump tear liquid under the covering such that the covering can remain in the eye and correct vision for an extended amount of time. In many embodiments, the covering comprises a material having fenestrations to draw tear liquid under the covering and an outer portion shaped to contact the conjunctiva over the sclera, such that when the eye closes pressure of one or more eyelids urges tear liquid through one or more fenestrations and under the outer portion shaped to contact the conjunctiva.
03/21/13
20130070201
Assessment of microvascular circulation
Methods and compositions are disclosed to quantitatively measure in vivo blood vessel diameter, blood velocity, and other flow dynamics. Such methods and compositions can optimize therapeutic interventions designed to prevent or reduce the risk of cardiovascular and blood disorders.
02/21/13
20130046325
Scleral buckling procedure and device
A resilient catheter includes a segmental balloon sized and configured so as to be capable of being directed under the conjunctiva toward a retinal tear, the segmental balloon further configured to produce a buckle inside the eye once inflated, and capable of being separated from a remaining part of the catheter while the segmental balloon is left in place for a period of time so as to heal the retinal tear.. .
01/03/13
20130006271
Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other uses
Methods and devices for ophthalmic tissue closure and fixation of ophthalmic prostheses are provided. In accordance with some embodiments, devices for both grasping and clipping a plurality of ocular tissue and ocular prostheses are provided.


Popular terms: [SEARCH]

Conjunctiva topics: Conjunctiva, Conjunctival, Ophthalmic, Presbyopia, Accommodation, Aqueous Humor, Anterior Chamber, Anterior Chamber Of The Eye, Prostaglandin, Intraocular, Treatments, Shape Memory Polymer, Cross Section, Neuropathy, Form Factor

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Conjunctiva for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Conjunctiva with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1622

1949

0 - 1 - 41